114 related articles for article (PubMed ID: 8040122)
21. Comparative efficacies of cloxacillin-daptomycin and the standard cloxacillin-rifampin therapies against an experimental foreign-body infection by methicillin-susceptible Staphylococcus aureus.
El Haj C; Murillo O; Ribera A; Vivas M; Garcia-Somoza D; Tubau F; Cabo J; Ariza J
Antimicrob Agents Chemother; 2014 Sep; 58(9):5576-80. PubMed ID: 24957833
[TBL] [Abstract][Full Text] [Related]
22. Efficacies of moxifloxacin, ciprofloxacin, and vancomycin against experimental endocarditis due to methicillin-resistant Staphylococcus aureus expressing various degrees of ciprofloxacin resistance.
Entenza JM; Que YA; Vouillamoz J; Glauser MP; Moreillon P
Antimicrob Agents Chemother; 2001 Nov; 45(11):3076-83. PubMed ID: 11600359
[TBL] [Abstract][Full Text] [Related]
23. Successful desensitization to cloxacillin in a patient with sepsis, with infective endocarditis and clinical suspicion of hypersensitivity to penicillins, a case report.
Marin S; Campins L; Miarons M; Pérez-Cordón L; Reina-Aguilar C; Solsona M
J Clin Pharm Ther; 2018 Dec; 43(6):921-924. PubMed ID: 30030968
[TBL] [Abstract][Full Text] [Related]
24. Paradoxical effect of cloxacillin and benzylpenicillin against clinical isolates in Staphylococcus aureus.
Odenholt I; Holm SE; Cars O
Chemotherapy; 1989; 35(5):345-50. PubMed ID: 2791711
[TBL] [Abstract][Full Text] [Related]
25. [Therapeutic effect of some antibiotics on experimental staphylococcal infection and its correlation with in vitro activity of antibiotics in sub-inhibitory concentration against Staphylococcus aureus strains].
Kaczmarska L; Jakoniuk P
Med Dosw Mikrobiol; 2003; 55(1):1-10. PubMed ID: 12908409
[TBL] [Abstract][Full Text] [Related]
26. Vancomycin minimum inhibitory concentration in methicillin-susceptible Staphylococcus aureus and mortality: more than handwaving?
Kaasch AJ; Jung N; Fätkenheuer G; Seifert H
Clin Infect Dis; 2015 Feb; 60(4):668. PubMed ID: 25371487
[No Abstract] [Full Text] [Related]
27. [Is methicillin better than cloxacillin in serious infections caused by strong penicillinase-producing staphylococci (phage-type 94/96)?].
Siboni AH; Jensen KT; Rosdahl VT; Gaub J
Ugeskr Laeger; 1995 Mar; 157(13):1862-4. PubMed ID: 7725565
[TBL] [Abstract][Full Text] [Related]
28. Significance of methicillin tolerance in experimental staphylococcal endocarditis.
Goldman PL; Petersdorf RG
Antimicrob Agents Chemother; 1979 Jun; 15(6):802-6. PubMed ID: 258111
[TBL] [Abstract][Full Text] [Related]
29. Intra- and Interinstitutional Evaluation of an Etest for Vancomycin Minimum Inhibitory Concentration Measurement in Staphylococcus aureus Blood Isolates.
Falcón R; Madrid S; Tormo N; Casañ C; Albert E; Gimeno C; Navarro D
Clin Infect Dis; 2015 Nov; 61(9):1490-2. PubMed ID: 26187018
[No Abstract] [Full Text] [Related]
30. Gentamicin may have no effect on mortality of staphylococcal prosthetic valve endocarditis.
Ramos-Martínez A; Muñoz Serrano A; de Alarcón González A; Muñoz P; Fernández-Cruz A; Valerio M; Fariñas MC; Gutiérrez-Cuadra M; Miró JM; Ruiz-Morales J; Sousa-Regueiro D; Montejo JM; Gálvez-Acebal J; HidalgoTenorio C; Domínguez F;
J Infect Chemother; 2018 Jul; 24(7):555-562. PubMed ID: 29628387
[TBL] [Abstract][Full Text] [Related]
31. Short-course therapy for right-side endocarditis due to Staphylococcus aureus in drug abusers: cloxacillin versus glycopeptides in combination with gentamicin.
Fortún J; Navas E; Martínez-Beltrán J; Pérez-Molina J; Martín-Dávila P; Guerrero A; Moreno S
Clin Infect Dis; 2001 Jul; 33(1):120-5. PubMed ID: 11389505
[TBL] [Abstract][Full Text] [Related]
32. LB11058, a new cephalosporin with high penicillin-binding protein 2a affinity and activity in experimental endocarditis due to homogeneously methicillin-resistant Staphylococcus aureus.
Vouillamoz J; Entenza JM; Hohl P; Moreillon P
Antimicrob Agents Chemother; 2004 Nov; 48(11):4322-7. PubMed ID: 15504859
[TBL] [Abstract][Full Text] [Related]
33. Reply to Kaasch et al.
Cervera C; Garcia de la Maria C; Pericas JM; Moreno A; Miro JM
Clin Infect Dis; 2015 Feb; 60(4):669-70. PubMed ID: 25371491
[No Abstract] [Full Text] [Related]
34. Role of granulocytes and monocytes in the prevention and therapy of experimental Staphylococcus epidermidis endocarditis in rabbits.
Meddens MJ; Thompson J; Mattie H; van Furth R
J Infect; 1985 Jul; 11(1):41-50. PubMed ID: 4031526
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetic and pharmacodynamic models of the antistaphylococcal effects of meropenem and cloxacillin in vitro and in experimental infection.
Mattie H; Zhang LC; van Strijen E; Sekh BR; Douwes-Idema AE
Antimicrob Agents Chemother; 1997 Oct; 41(10):2083-8. PubMed ID: 9333029
[TBL] [Abstract][Full Text] [Related]
36. [Cloxacillin-susceptible Staphylococcus aureus with high MIC to glycopeptides. Ever we use cloxacillin?].
Morales-Cartagena A; Lalueza A; San Juan R; Aguado JM
Rev Esp Quimioter; 2015 Sep; 28 Suppl 1():25-9. PubMed ID: 26365730
[TBL] [Abstract][Full Text] [Related]
37. Treatment of Staphylococcus aureus endocarditis: an analysis based on 25 proven cases.
Freeman R; Jones MR; Gould FK
Eur Heart J; 1986 Aug; 7(8):679-84. PubMed ID: 3769952
[TBL] [Abstract][Full Text] [Related]
38. Role of intravenous cloxacillin for inpatient infections.
Bru JP; Garraffo R
Med Mal Infect; 2012 Jun; 42(6):241-6. PubMed ID: 22542764
[TBL] [Abstract][Full Text] [Related]
39. [Characteristics and treatment of Staphylococcus aureus endocarditis].
Zou Q; Hu P; Jiang Y
Zhonghua Nei Ke Za Zhi; 1996 Jul; 35(7):455-7. PubMed ID: 9592316
[TBL] [Abstract][Full Text] [Related]
40. Cefazolin versus cloxacillin in methicillin-susceptible Staphylococcus aureus endocarditis: Too good to be true? Authors' reply.
Herrera-Hidalgo L; de Alarcón A
Int J Infect Dis; 2024 May; 142():106979. PubMed ID: 38401779
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
